Answer
Yes, patients taking Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Gilead may still develop opportunistic infections and other HIV complications, so they should remain under close clinical observation by physicians experienced in treating HIV-associated diseases.
Sources for this answer
- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Gilead 150mg/150mg/200mg/10mg film coated tabletsGilead Sciences Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 37Document updated
Sources checked